ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Disease
Dust Mite Allergy

Asthma trials near Charlotte, NC, USA:

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: Placebo
Drug: GB-0895

Phase 3

Generate Biomedicines

Gastonia, North Carolina, United States and 133 other locations

Locations recently updated

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

Rock Hill, South Carolina, United States and 156 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Charlotte, North Carolina, United States and 335 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Charlotte, North Carolina, United States and 14 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Charlotte, North Carolina, United States of America and 136 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Inhaled corticosteroids/long-acting beta-2 agonists
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Charlotte, North Carolina, United States and 116 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Charlotte, North Carolina, United States and 83 other locations

medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breat...

Enrolling
Asthma
Other: Placebo
Drug: tilrekimig

Phase 3

Pfizer
Pfizer

Monroe, North Carolina, United States of America and 15 other locations

of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and participants with mild-to-moderate asthma...

Active, not recruiting
Asthma
Drug: Placebo
Drug: AMG 691

Phase 1

Amgen
Amgen

Monroe, North Carolina, United States of America and 20 other locations

This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...

Enrolling
Eosinophilic Asthma
Drug: KT-621
Other: Placebo

Phase 2

Kymera Therapeutics

Rock Hill, South Carolina, United States and 80 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems